Basilea Pharmaceutica
Switzerland - AllschwilBiotechnology
Focus: Basilea Pharmaceutica is a Swiss-headquartered public biotech focused on specialty pharmaceuticals in topical, infectious disease, oncology, and immunology applications. The company operates as a mid-cap biotech with a diversified pipeline across multiple therapeutic areas.
Profile data last refreshed 11h ago · AI intelligence enriched 4d ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at Basilea Pharmaceutica?
AI assessmentBest fit for scientists seeking deep pipeline exposure and regulatory mentorship in a stable public biotech; less suitable for those prioritizing rapid hiring, commercial scaling, or near-term IPO/exit events.
Why Work Here
- Access to a mature public biotech with 18 active clinical programs, including three Phase 3 candidates (ceftobiprole, alitretinoin, fosmanogepix) offering near-term catalysts and regulatory visibility.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Help build intelligence for Basilea Pharmaceutica
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.